- Report
- May 2025
- 192 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 179 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 194 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 197 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 193 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 187 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 196 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 196 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 292 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 196 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 324 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 657 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 427 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 573 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 293 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- May 2025
- 411 Pages
Global
From €5380EUR$5,850USD£4,553GBP
- Report
- November 2024
- 164 Pages
Global
From €2299EUR$2,500USD£1,946GBP
- Report
- November 2024
- 165 Pages
Global
From €2299EUR$2,500USD£1,946GBP
- Report
- July 2024
- 136 Pages
Global
From €2299EUR$2,500USD£1,946GBP
- Report
- May 2024
- 170 Pages
Global
From €2299EUR$2,500USD£1,946GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more